Preventing and controlling emerging and reemerging transmissible diseases in the homeless

Emerging Infectious Diseases

Volumn 14, Issue 9, 2008, Pages 1353-1359

  Badiaga, Sékéné ^a   Raoult, Didier ^a,b   Brouqui, Philippe ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BENZYL BENZOATE; CROTAMITON; DOXYCYCLINE; GENTAMICIN; HEPATITIS B VACCINE; IVERMECTIN; LINDANE; PERMETHRIN; PLACEBO;

AIRBORNE INFECTION; BACTEREMIA; BARTONELLA QUINTANA; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; DIPHTHERIA; DIRECTLY OBSERVED THERAPY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; EPIDEMIC; HEALTH HAZARD; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS; HEPATITIS A; HEPATITIS B; HEPATITIS C; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INCIDENCE; INFLUENZA; LOBAR PNEUMONIA; PATIENT EDUCATION; PREVALENCE; PROPHYLAXIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; RISK REDUCTION; SCABIES; SCREENING TEST; SYMPTOMATOLOGY; TUBERCULIN TEST; TUBERCULOSIS; TYPHUS;

ANIMALS; ANTITUBERCULAR AGENTS; BARTONELLA QUINTANA; COMMUNICABLE DISEASES, EMERGING; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; LICE INFESTATIONS; PEDICULUS; PREVALENCE; PUBLIC HEALTH; SCABIES; TRENCH FEVER; TUBERCULOSIS;

EID: 50849083182     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1409.080204     Document Type: Review

References (40)

1. Hwang SW. Homelessness and health. CMAJ. 2001;164:229-33.
2. Burt MR, Aron LY. Helping America's homeless. Washington: Urban Institute; 2001.
3. Raoult D, Foucault C, Brouqui P. Infections in the homeless. Lancet Infect Dis. 2001;1:77-84. DOI: 10.1016/S1473-3099(01)00062-7
4. Haddad MB, Wilson TW, Ijaz K, Marks SM, Moore M. Tuberculosis and the homelessness in the United States, 1993-2003. JAMA. 2005;293:2762-6. DOI: 10.1001/jama.293.22.2762
5. Brouqui P, Stein A, Tissot Dupont H, Gallian P, Badiaga S, Rolain JM, et al. Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles. Medicine (Baltimore). 2005;84:61-8. DOI: 10.1097/01.md.0000152373. 07500.6e
6. Robertson MJ, Clark RA, Charlebois ED, Tulsky J, Long HL, Bangsberg DR, et al. HIV seroprevalence among homeless and marginally housed in San Francisco. Am J Public Health. 2004;94:1207-17.
7. Barnes PF, Yang Z, Pogoda JM, Preston-Martin S, Jones B, Otaya M, et al. Foci of tuberculosis transmission in central Los Angeles. Am J Respir Crit Care Med. 1999;159:1081-6.
8. Syed NA, Hearing SD, Shaw SL, Probert CSJ, Brooklyn TN, Caul EO, et al. Outbreak of hepatitis A in the injecting drug user and homeless population in Bristol: control by a targeted vaccination programme and possible parenteral transmission. Eur J Gastroenterol Hepatol. 2003;15:901-6. DOI: 10.1097/00042737-200308000-00011
9. Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003;44:293-302. DOI: 10.1016/S0010-440X(03)00094- 4
10. Beech BM, Myers L, Beech DJ, Kernick NS. Human immunodeficiency syndrome and hepatitis B and C infections among homeless adolescents. Semin Pediatr Infect Dis. 2003;14:12-9. DOI: 10.1053/spid.2003.127212
11. Badiaga S, Menard A, Tissot Dupont H, Ravaux I, Chouquet D, Graveriau C, et al. Prevalence of skin infections in sheltered homeless. Eur J Dermatol. 2005;15:382-6.
12. Arfi C, Dehen L, Benassaia E, Faure P, Farge D, Morel P, et al. Dermatologic consultation in a precarious situation: a prospective medical and social study at the Hôpital Saint-Louis in Paris [in French]. Ann Dermatol Venereol. 1999;126:682-6.
13. Rydkina EB, Roux V, Gagua EM, Predtechenski AB, Tarasevitch IV, Raoult D. Bartonella quintana in body lice collected from homeless persons in Russia. Emerg Infect Dis. 1999;5:176-8.
14. Seki N, Sasaki T, Sawabe K, Sasaki T, Matsuoka M, Arakawa Y, et al. Epidemiological studies on Bartonella quintana infections among homeless people in Tokyo, Japan. Jpn J Infect Dis. 2006;59:31-5.
15. Brouqui P, Lascola B, Roux V, Raoult D. Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med. 1999;340:184-9. DOI: 10.1056/NEJM199901213400303
16. Rotheram-Borus MJ, Song J, Gwadz M, Lee M, Van Rossem R, Koopman C. Reductions in HIV risk among runaway youth. Prev Sci. 2003;4:173-87. DOI: 10.1023/A:1024697706033
17. Kong PM, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, et al. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis. 2002;8:1280-4.
18. Foucault C, Ranque S, Badiaga S, Rovery C, Raoult D, Brouqui P. Oral ivermectin in the treatment of body lice. J Infect Dis. 2006;193:474-6. DOI: 10.1086/499279
19. Wechsberg WM, Lam WKK, Zule WA, Bobashev G. Efficacy of a woman-focused intervention to reduce HIV risk and increase selfsufficiency among African American crack abusers. Am J Public Health. 2004;94:1165-73.
20. Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S, Wolf F, et al. A syringe prescription program to prevent infectious disease and improve health of injection drug users. J Urban Health. 2004;81:122-34. DOI: 10.1093/jurban/jth092
21. Altice FL, Bruce RD, Walton MR, Buitrago MI. Adherence to hepatitis B vaccination at syringe exchange sites. J Urban Health. 2005;82:151-61. DOI: 10.1093/jurban/jti016
22. Wright NM, Campbell TL, Tompkins CN. Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users. Commun Dis Public Health. 2002;5:324-6.
23. Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless. Am J Respir Crit Care Med. 2000;162:460-4.
24. Kimerling ME, Shakes CF, Carliste R, Lok KH, Benjamin WH, Dunlap NE. Spot sputum screening: evaluation of an intervention in two homeless shelters. Int J Tuberc Lung Dis. 1999;3:613-9.
25. Southern A, Premaratne N, English M, Balazs J, O'Sullivan D. Tuberculosis among homeless people in London: an effective model of screening and treatment. Int J Tuberc Lung Dis. 1999;3:1001-8.
26. Jones TF, Schaffner W. Miniature chest radiograph screening for tuberculosis in jails: a coast-effectiveness analysis. Am J Respir Crit Care Med. 2001;164:77-81.
27. Badiaga S, Richet H, Azas P, Rey F, Tissot Dupont H, Foucault C, et al. Prevalence of respiratory diseases in sheltered homeless people in Marseille, France. In: Abstracts of the 16th European Congress of Clinical Microbiology and Infectious Diseases; Nice, France, 2006 Apr 1-4. Abstract O420. Nice (France): The Congress; 2006.
28. Brewer TF, Heymann SJ, Krumplitsch SM, Wilson ME, Colditz GA, Fineberg HV. Strategies to decrease tuberculosis in US homeless populations: a computer simulation model. JAMA. 2001;286:834-42. DOI: 10.1001/jama.286.7.834
29. Bucher SJ, Brickner PW, Vincent RL. Influenzalike illness among homeless persons. Emerg Infect Dis. 2006;12:1162-3.
30. Mercat A, Nguyen J, Dautzenberg B. An outbreak of pneumococcal pneumonia at two men's shelters. Chest. 1991;99:147-51. DOI: 10.1378/chest.99.1.147
31. Raoult D, Ndihokubwayo JB, Tissot-dupont H, Roux V, Faugere B, Abegbinni R, et al. Outbreak of epidemic typhus associated with trench fever in Burundi. Lancet. 1998;352:353-8. DOI: 10.1016/ S0140-6736(97)12433-3
32. La Scola B, Raoult D. Acinetobacter baumanii in human body louse. Emerg Infect Dis. 2004;10:1671-3.
33. Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006;354:1718-27. DOI: 10.1056/NEJMcp052784
34. Foucault C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerg Infect Dis. 2006;12:217-23.
35. Drancourt M, Mainardi JL, Brouqui P, Vandenesch F, Carta A, Lehnert F, et al. Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med. 1995;332:419-23. DOI: 10.1056/ NEJM199502163320702
36. Spach DH, Kanter AS, Dougherty MJ, Larson AM, Coyle MB, Brenner DJ, et al. Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med. 1995;332:424-8. DOI: 10.1056/NEJM199502163320703
37. Rolain JM, Foucault C, Guieu R, La Scola B, Brouqui P, Raoult D. Bartonella quintana in human erythrocytes. Lancet. 2002;360:226-8. DOI: 10.1016/S0140-6736(02)09462-X
38. Foucault C, Raoult D, Brouqui P. Randomized open trial of gentamycin and doxycycline for of Bartonella quintana from blood in patients with chronic bacteremia. Antimicrob Agents Chemother. 2003;47:2204-7. DOI: 10.1128/AAC.47.7.2204-2207.2003
39. Badiaga S, Brouqui P, Raoult D. Autochthonous epidemic typhus associated Bartonella quintana bacteremia in a homeless person. Am J Trop Med Hyg. 2005;72:638-9.
40. Brouqui P, Badiaga S, Raoult D. Q fever outbreak in homeless shelter. Emerg Infect Dis. 2004;10:1297-9.